LFCR
Price
$6.87
Change
-$0.00 (-0.00%)
Updated
Jun 3 closing price
Capitalization
176.87M
84 days until earnings call
NBIX
Price
$125.00
Change
+$0.44 (+0.35%)
Updated
Jun 3 closing price
Capitalization
13.72B
62 days until earnings call
Interact to see
Advertisement

LFCR vs NBIX

Header iconLFCR vs NBIX Comparison
Open Charts LFCR vs NBIXBanner chart's image
Lifecore Biomedical
Price$6.87
Change-$0.00 (-0.00%)
Volume$142.12K
Capitalization176.87M
Neurocrine Biosciences
Price$125.00
Change+$0.44 (+0.35%)
Volume$1.31M
Capitalization13.72B
LFCR vs NBIX Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. NBIX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and NBIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (LFCR: $6.87 vs. NBIX: $125.00)
Brand notoriety: LFCR and NBIX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 46% vs. NBIX: 77%
Market capitalization -- LFCR: $176.87M vs. NBIX: $13.72B
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFCR and NBIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 3 bearish.
  • NBIX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than NBIX.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -1.86% price change this week, while NBIX (@Pharmaceuticals: Other) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.58%. For the same industry, the average monthly price growth was +15.20%, and the average quarterly price growth was +63.51%.

Reported Earning Dates

LFCR is expected to report earnings on Aug 27, 2025.

NBIX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.58% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: -7.537 vs. NBIX (-8.425). NBIX has higher annual earnings (EBITDA): 358M vs. LFCR (-22.64M). NBIX has more cash in the bank: 1.03B vs. LFCR (4.22M). LFCR has less debt than NBIX: LFCR (157M) vs NBIX (428M). NBIX has higher revenues than LFCR: NBIX (1.89B) vs LFCR (188M).
LFCRNBIXLFCR / NBIX
Capitalization177M13.7B1%
EBITDA-22.64M358M-6%
Gain YTD-7.537-8.42589%
P/E RatioN/A57.20-
Revenue188M1.89B10%
Total Cash4.22M1.03B0%
Total Debt157M428M37%
FUNDAMENTALS RATINGS
LFCR vs NBIX: Fundamental Ratings
LFCR
NBIX
OUTLOOK RATING
1..100
7922
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4949
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (72) in the Biotechnology industry is in the same range as LFCR (92) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's SMR Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's Price Growth Rating (49) in the Biotechnology industry is in the same range as LFCR (49) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRNBIX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 13 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ICX.X0.1342820.004160
+3.20%
ICON cryptocurrency
LTO.X0.0349600.000658
+1.92%
LTO Network cryptocurrency
C98.X0.0533430.000469
+0.89%
Coin98 cryptocurrency
LIT.X0.000128-0.000001
-0.74%
Lition cryptocurrency
GALA.X0.017092-0.000199
-1.15%
Gala cryptocurrency

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
N/A
SHPH - LFCR
31%
Poorly correlated
-3.06%
OGI - LFCR
27%
Poorly correlated
+1.53%
ALKS - LFCR
27%
Poorly correlated
-0.06%
AMRX - LFCR
27%
Poorly correlated
+0.40%
TLRY - LFCR
27%
Poorly correlated
-1.65%
More